Fletcher, C V <br/><br/>
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  May 1991 
 - 938-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.35.5.938  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--pharmacokinetics<br/>Adolescent<br/>Adult<br/>Aged<br/>Creatinine--blood<br/>Cytomegalovirus--drug effects<br/>Cytomegalovirus Infections--microbiology<br/>Humans<br/>Kidney Transplantation<br/>Leukocyte Count<br/>Middle Aged